Breast Cancer

Breast Cancer

乳腺癌

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Breast Cancer》是由Springer Japan出版社于1994年创办的英文国际期刊(ISSN: 1340-6868,E-ISSN: 1880-4233),该期刊长期致力于妇产科学领域的创新研究,主要研究方向为ONCOLOGY-OBSTETRICS & GYNECOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA未开放获取模式(OA占比0.1304...%),以发表妇产科学领域等方向的原创性研究为核心(研究类文章占比91.75%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在97篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Breast Cancer审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约97篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 97 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学
3区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学
3区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:OBSTETRICS & GYNECOLOGY SCIE Q1 14 / 136

90.1%

学科:ONCOLOGY SCIE Q2 95 / 322

70.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OBSTETRICS & GYNECOLOGY SCIE Q2 39 / 136

71.69%

学科:ONCOLOGY SCIE Q2 87 / 322

73.14%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.7 SJR:1.054 SNIP:1.049
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q1 56 / 333

83%

大类:Medicine 小类:Pharmacology (medical) Q1 60 / 272

78%

大类:Medicine 小类:Oncology Q2 105 / 404

74%

期刊发文

  • Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node

    Author: Liao, Ning; Li, Cheukfai; Cao, Li; Chen, Yanhua; Ren, Chongyang; Chen, Xiaoqing; Mok, Hsiaopei; Wen, Lingzhu; Li, Kai; Wang, Yulei; Zhang, Yuchen; Li, Yingzi; Lv, Jiaoyi; Cao, Fangrong; Luo, Yuting; Li, Hongrui; Wu, Wendy; Balch, Charles M.; Giuliano, Armando E.

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 1, pp. 77-87. DOI: 10.1007/s12282-022-01400-x

  • Conservative axillary surgery is emerging in the surgical management of breast cancer

    Author: Noguchi, Masakuni; Inokuchi, Masafumi; Yokoi-Noguchi, Miki; Morioka, Emi; Haba, Yusuke

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 1, pp. 14-22. DOI: 10.1007/s12282-022-01409-2

  • Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer

    Author: Ma, Jiulong; Wang, Fengjun; Chen, Chen; Ji, Jiahua; Huang, Peng; Wei, Dexian; Zhang, Yang; Ren, Liqun

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 379-392. DOI: 10.1007/s12282-023-01433-w

  • Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis

    Author: Jiao, Yile; Guo, Xinyi; Lv, Qing

    Journal: BREAST CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12282-023-01459-0

  • HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC

    Author: Li, Jing-Jing; Yu, Yue; Ge, Jie

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 364-378. DOI: 10.1007/s12282-022-01431-4

  • Construction and characterization of a cuproptosis- and immune checkpoint-based LncRNAs signature for breast cancer risk stratification

    Author: Li, Yan; Na, Feiyang; Pei, Jianying

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 393-411. DOI: 10.1007/s12282-023-01434-9

  • Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)

    Author: Imoto, Shigeru; Wang, Kun; Bi, Xi-wen; Liu, Guangyu; Im, Young-Hyuck; Im, Seock-Ah; Sim, Sung Hoon; Ueno, Takayuki; Futamura, Manabu; Toi, Masakazu; Fujiwara, Yasuhiro; Ahn, Sung Gwe; Lee, Jeong Eon; Park, Yeon Hee; Takao, Shintaro; Oba, Mari Saito; Kitagawa, Yuko; Nishiyama, Masahiko

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 412-423. DOI: 10.1007/s12282-023-01436-7

  • Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer

    Author: Qing, Xin; Yuan, Chunlei; Wang, Ke

    Journal: BREAST CANCER. 2023; Vol. 30, Issue 3, pp. 424-435. DOI: 10.1007/s12282-023-01435-8